Qinghe Song1, Beibei Mao2, Jinbo Cheng2, Yuhao Gao1, Ke Jiang3, Jun Chen4, Zengqiang Yuan1, Songshu Meng3. 1. State Key Laboratory of Brain and Cognitive Sciences, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China. 2. State Key Laboratory of Brain and Cognitive Sciences, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China. 3. Institute of Cancer Stem Cell, Dalian Medical University Cancer Center, Dalian, Liaoning, China. 4. Center of Growth, Metabolism and Aging, College of Life Sciences, Sichuan University, Chengdu, China.
Abstract
The Yes-associated protein (YAP), a transcriptional coactivator inactivated by the Hippo tumor suppressor pathway, functions as an oncoprotein in a variety of cancers. However, its contribution to breast cancer remains controversial. This study investigated the role of YAP in breast cancer cells under nutrient deprivation (ND). Here, we show that YAP knockdown sensitized MCF7 breast cancer cells to nutrient deprivation-induced apoptosis. Furthermore, in response to ND, YAP increased the autolysosome degradation, thereby enhancing the cellular autophagic flux in breast cancer cells. Of note, autophagy is crucial for YAP to protect MCF7 cells from apoptosis under ND conditions. In addition, the TEA domain (TEAD) family of growth-promoting transcription factors was indispensable for YAP-mediated regulation of autophagy. Collectively, our data reveal a role for YAP in promoting breast cancer cell survival upon ND stress and uncover an unappreciated function of YAP/TEAD in the regulation of autophagy.
The Yes-associated protein (YAP), a transcriptional coactivator inactivated by the Hippo tumor suppressor pathway, functions as an oncoprotein in a variety of cancers. However, its contribution to breast cancer remains controversial. This study investigated the role of YAP in breast cancer cells under nutrient deprivation (ND). Here, we show that YAP knockdown sensitized MCF7breast cancer cells to nutrient deprivation-induced apoptosis. Furthermore, in response to ND, YAP increased the autolysosome degradation, thereby enhancing the cellular autophagic flux in breast cancer cells. Of note, autophagy is crucial for YAP to protect MCF7 cells from apoptosis under ND conditions. In addition, the TEA domain (TEAD) family of growth-promoting transcription factors was indispensable for YAP-mediated regulation of autophagy. Collectively, our data reveal a role for YAP in promoting breast cancer cell survival upon ND stress and uncover an unappreciated function of YAP/TEAD in the regulation of autophagy.
The Hippo/MST pathway plays a key role in tissue homeostasis and organ size control [1,2]. A major downstream target of the Hippo/MST pathway is the mammalian transcriptional coactivator Yes-associated protein (YAP). YAP shuttles between the cytoplasm and nucleus, where it activates the TEA domain (TEAD) family of growth-promoting transcription factors to regulate gene expression [3]. The human chromosome 11q22 amplicon, which encompasses the YAP gene, is frequently amplified in multiple types of humancancers [4-6]. Furthermore, increased expression and/or nuclear accumulation of YAP were observed in a variety of humancancers [7-9], indicating a role for YAP as a candidate oncogene in tumorigenesis.In breast cancer, however, the role of YAP in cancer development remains controversial. Loss of heterozygosity (LOH) of the YAP gene locus (located at 11q22.2) was frequently detected in sporadic breast cancer [10-14], suggesting that YAP may function as a tumor suppressor. In addition, reduced expression of YAP in invasive carcinoma is associated with estrogen receptor α (ERα) and progesterone receptor (PR) negativity in invasive breast carcinomas [15]. Loss of YAP expression contributes to the suppression of anoikis, the increased migration and invasiveness and the enhanced tumor growth in nude mice [16]. These findings support a role of YAP as tumor suppressor gene in breast cancer. However, contrasting observations suggest an oncogenic role for YAP in breast cancer [17]. Over-expression of YAP in human non-transformed mammary epithelial MCF-10A cells leads to phenotypic alterations that are hallmarks of tumorigenic transformation [6]. In addition, a very recent report showed that loss of YAP suppresses oncogene-induced tumor growth in mouse mammary glands [9]. Collectively, the role of YAP in breast cancer is complex and needs to be further investigated.Macroautophagy (hereafter referred to as autophagy) is an evolutionarily conserved lysosome-dependent cellular catabolic degradation pathway. The hallmark of autophagy is the formation of double- or multi-membrane vesicles in the cytosol, called autophagosomes, which encapsulate bulk cytoplasm and cytoplasmic organelles [18]. The outer membrane of the autophagosome then fuses with endosomes or lysosomes to form autolysosomes that degrade their content. The degradation products can be used as sources of energy during periods of metabolic stress (e.g., starvation), thereby promoting cell survival [19,20]. In a tumor microenvironment, autophagy can promote cancer cell survival in response to harmful stress [21-23]. Autophagy delays apoptotic death in noninvasive breast cancer cells following DNA damage [24]. On the other hand, progressive autophagy can also induce cell death [25]. Therefore, there is likely a balance between oncogenic and tumor suppressive autophagy during tumorigenesis.Recently, Maejima et al. showed that mammalian STE20-like kinase-1 (MST-1) subverts autophagy and promotes apoptosis in the heart [26], suggesting a role for the MST/YAP pathway in integrating autophagy and apoptosis during cellular stress. This finding motivated us to analyze whether YAP could modulate autophagy in a cancer setting. In this work, we have found that autophagy is critical for YAP to protect MCF7breast cancer cells from apoptosis under nutrient deprivation conditions. Importantly, YAP modulates autophagic flux by enhancing autolysosome degradation. Therefore, our study suggests a role for YAP in regulating autophagy and promoting breast cancer cell survival under nutrient deprivation conditions.
Materials and Methods
Cell culture and reagents
Humanbreast cancerMCF7 and MDA-MB-231 cells were purchased from American Type Culture Collection (ATCC) and maintained in Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen) with 10% fetal bovine serum (FBS, Invitrogen) and penicillin/streptomycin in a humidified incubator under 95% air and 5% CO2 at 37°C. For nutrient deprivation (ND), cells were incubated in Earle’s Balanced Salt Solution (EBSS, without glucose) after 2 times of washing with EBSS. All other cell culture materials were obtained from Thermo and all chemicals were obtained from Sigma-Aldrich.Concentrations of chemicals used to treat cells are as follows: Chloroquine (CQ, 25μM), Bafilomycin A1 (BafA1, 10nM), Rapamycin (Rapa, 20μM), 3-Methyladenine (3-MA, 5mM), NH4Cl (20mM).
Lentiviral shRNA cloning, production, and infection
All short hairpin RNAs (shRNA) were cloned into plko.1-vector. TEADs shRNAs were designed in a region identical in TEAD1, 3, and 4.The targeted sequences are as follows: shYAP, 3’-GACATCTTCTGGTCAGAGA-5’; shTEADs, ATGATCAACTT CATCCACAAG; scrambled control RAN interference sequence (shCtrl), 3’-GACATTTGTAACGGGATTC-5’.The lentivirus production and infection were performed as described previously [27]. Resulting control and YAP or TEADs knockdown cell lines were called shCtrl, shYAP and shTEADs respectively.
Retrovirus infection
To generate wild-type (WT) or mutant YAP-expressing stable cells, retrovirus infection was performed as previously reported [28]. The pQCXIH empty vector, pQCXIH-YAP WT and S94A constructs are gifts from Zhao Bin (Zhejiang University, China). The control and WT YAP-overexpressing stable cell lines were called Ctrl and YAP, respectively. The YAP rescue mutant was obtained as described previously [27]. MCF7-shYAP cells were separately infected with retrovirus expressing YAP-WT and YAP-S94A to generate the stable cell lines WT Res and S94A Res.
Stable cell lines
MCF7-shCtrl and shYAP cells were stably transfected with plasmid expressing tandem fluorescent mRFP-GFP-tagged LC3 (tfLC3) (a gift from Dr. T. Yoshimori from Osaka University, Osaka, Japan) [29]. The resulting cell lines were called MCF7-shCtrl-tfLC3 and MCF7-shYAP-tfLC3. Cells with high-fluorescence-intensity puncta in the MCF7-shYAP-tfLC3 cell line were selected by flow cytometry. The resulting high-fluorescence-intensity-puncta cell line was named tfLC3-shYAP, and subsequently stably infected with retrovirus expressing YAP-WT or YAP-S94A to generate the tfLC3-WTr and tfLC3-S94Ar cell lines.
Transfections
siRNA transfections were performed with Lipofectamine 2000 (Life Technologies) according to the manufacturer's instructions. Sequences of siRNA are as follows: LC3 1#, 3’-uaauuagaaggcgcuuaca-5’; LC3 2#, 3’-uagaacgauacaaggguga-5’.
MTT assay
The cell viability was determined by MTT assay. Cells were seeded in 96-well flat plate for 24 h. After designated treatments, the MTT assay was performed as previously described [30]. Quantitative analysis of relative cell viability was derived from triplicates. The experiments were repeated three times.
Immunofluorescence
Immunofluorescence were conducted as described previously [31].
Hoechst staining
Apoptotic nuclear changes were examined using Hoechst 33258 (Sigma). The cells were fixed with 4% paraformaldehyde, stained with Hoechst 33258 for 10 min. All the nuclear morphology images were obtained using a fluorescence microscope (Carl Zeiss).
Cell apoptosis assay
Apoptosis was determined by flow cytometric analysis of membrane redistribution of phosphatidylserine using an Annexin V-FITC and propidium iodide (PI) double staining technique. The experiment was performed as described previously [30]. Apoptotic cells were expressed as the percentage of both early stage (PI negative and Annexin V positive) and late stage (PI positive and Annexin V positive) populations. Surviving cells were the PI negative and Annexin V negative population. Quantitative analysis of percentage of apoptotic cells was derived from triplicates. The experiments were repeated three times.
Western blotting
Western blot analyses were conducted as described previously [32]. Densitometry analysis of the Western blotting bands was performed using ImageJ software. The quantified results were calculated from three independent experiments. The primary antibodies were used as follows: YAP (NOVUS, NB110-58308), TEAD4 (Sigma, WH0007004M1), microtubule-associated protein1 light chain 3 (LC3) (Cell Signaling, #2775), p62 (MBL, pm045), S6 ribosomal protein (Cell Signaling, #2217), and phospho-S6 ribosomal protein (ser235/236) (Cell Signaling, #2211).
Confocal microscopy
Cells stably expressing tandem fluorescent mRFP-GFP-tagged LC3 (tfLC3) were seeded in glass bottom cell culture dishes (NEST, 801002) and cultured for 24 h. After treatments, fluorescent images were directly taken from live cells using an inverted confocal microscope (Leica). For quantification of autophagic cells, fluorescent puncta were determined from triplicates by counting more than 30 cells per field.
High content cells assay
MCF7-tfLC3-shYAP, tfLC3-WTr and tfLC3-S94Ar cells were seeded in 24-well plates and cultured for 24 h. After the designated treatments, average red and green fluorescent intensity per live cell in each well was directly measured by a high content cell assay microscope system (Thermo). The quantified results were given as the ratios of GFP/RFP fluorescent intensity from triplicates.
Acid phosphatase activity assay
MCF7-shCtrl, shYAP and YAP Res cells were seeded in 6-well plates and cultured for 24 h. The lysates were assayed by the Acid Phosphatase Assay Kit (Sigma-Aldrich, CS0740) following the protocol of the product.
Lysosomal acidification level assay
MCF7-shCtrl, shYAP and YAP Res cells were seeded in 6-well plates for 24 h and then detached by trypsin-EDTA. Cells were resuspended in 500 μL of fresh culture medium. We added 1 μL of LysoTracker Red DND 90 (50μM, Invitrogen, L7528) to each cell suspension and incubated it at 37°C for 10 min. The stained cells were assayed by flow cytometer (BD FACS AriaIII).
Statistical analysis
Results are reported as the means±SEM. Comparisons between two groups were accomplished using an unpaired Student’s t test. P<0.05 was considered statistically significant.
Results
YAP knockdown sensitizes MCF7 cells to nutrient deprivation-induced apoptosis
To determine if YAP protein levels interfere with the sensitivity of breast cancer cells to nutrient deprivation (ND), YAP was stably knocked down in MCF7 cells (control and YAP knockdown cell lines are called shCtrl and shYAP hereafter). YAP rescue protein was then stably expressed in MCF7-shYAP cells (hereafter called YAP Res) (Fig. 1A). These cells were cultured in EBSS to mimic the ND environment. After 36 h of ND, cell viability was determined by MTT assay. As shown in Fig. 1B, there were significantly more viable shCtrl cells compared with shYAP cells. Additionally, more viable cells were observed in YAP Res cells compared with shYAP cells. Consistent results were observed using MDA-MB-231 cells (S1 Fig.). These data indicate that YAP knockdown results in reduced survival under ND conditions. Next, we examined whether the reduced survival induced by YAP knockdown was due to apoptosis by performing flow cytometry using Annexin V-FITC/PI double staining. After ND treatment, there were more apoptotic and fewer survival populations in shYAP cells than in either shCtrl or YAP Res cells (Fig. 1C, 1D and 1E). There were also markedly more shrunken and detached shYAP cells than shCtrl or YAP Res cells (Fig. 1F). Further examination by Hoechst staining showed that apoptotic chromatin condensation was more frequently detected in shYAP cells under ND (Fig. 1G). The level of cleaved poly (ADP-ribose) polymerase (PARP), a marker of cells undergoing apoptosis [33], increased markedly in shYAP cells compared to shCtrl cells after ND treatment (Fig. 1H). In line with a recent study by Liang et al [34], we observed that after ND treatment, YAP levels decreased with time, which possibly increased the apoptosis. Altogether, these data indicate that YAP may play an important role in protecting MCF7 cells from apoptosis in response to ND stress.
Fig 1
Nutrient deprivation-induced apoptosis in MCF7 cells is increased by YAP knockdown.
(A) Expression of YAP in MCF7-shCtrl, shYAP and YAP Res cells was detected by Western blotting. (B) MCF7-shCtrl, shYAP and YAP Res cells were cultured in normal medium or EBSS for 36 h. Cell viability was determined by MTT assay. Data are shown as the means±SEM. *P<0.05, n = 3. (C) After 36 h of ND, cells were stained by Annexin V-FITC/PI and analyzed with flow cytometry. Representative results are shown. (D) Quantitative analysis of the percentage of surviving cells according to the results of (C) is shown. The numbers of surviving cells are expressed as the percentage of Annexin V-FITC/PI double negative cells out of the total number of cells in the gate. Data are shown as the means±SEM. *P<0.05, n = 3. (E) Quantitative analysis of the percentages of apoptotic cells, according to the results of (C) is shown. The numbers of apoptotic cells are expressed as the percentage of Annexin V-positive cells out of the total number of cells in the gate. Data are shown as the means±SEM. *P<0.05, n = 3. (F) Cells were maintained in normal medium or EBSS (ND) for 36 h. Cell morphology was examined by inverted phase contrast microscopy. Representative morphologic images are shown. (G) Nuclear morphology was investigated using Hoechst staining after treatment as in (F). (H) MCF7-shCtrl and shYAP cells were cultured in the indicated conditions for the indicated time. Total proteins were subjected to Western blotting for cleaved PARP. The results are representative of two independent experiments.
Nutrient deprivation-induced apoptosis in MCF7 cells is increased by YAP knockdown.
(A) Expression of YAP in MCF7-shCtrl, shYAP and YAP Res cells was detected by Western blotting. (B) MCF7-shCtrl, shYAP and YAP Res cells were cultured in normal medium or EBSS for 36 h. Cell viability was determined by MTT assay. Data are shown as the means±SEM. *P<0.05, n = 3. (C) After 36 h of ND, cells were stained by Annexin V-FITC/PI and analyzed with flow cytometry. Representative results are shown. (D) Quantitative analysis of the percentage of surviving cells according to the results of (C) is shown. The numbers of surviving cells are expressed as the percentage of Annexin V-FITC/PI double negative cells out of the total number of cells in the gate. Data are shown as the means±SEM. *P<0.05, n = 3. (E) Quantitative analysis of the percentages of apoptotic cells, according to the results of (C) is shown. The numbers of apoptotic cells are expressed as the percentage of Annexin V-positive cells out of the total number of cells in the gate. Data are shown as the means±SEM. *P<0.05, n = 3. (F) Cells were maintained in normal medium or EBSS (ND) for 36 h. Cell morphology was examined by inverted phase contrast microscopy. Representative morphologic images are shown. (G) Nuclear morphology was investigated using Hoechst staining after treatment as in (F). (H) MCF7-shCtrl and shYAP cells were cultured in the indicated conditions for the indicated time. Total proteins were subjected to Western blotting for cleaved PARP. The results are representative of two independent experiments.
Autophagy is crucial for YAP to protect MCF7 cells from apoptosis under ND conditions
Nutrient deprivation (ND) induces the autophagy that promotes survival of different cancer cells [35]. We asked whether autophagy plays a role in the apoptotic increase in YAP knockdown MCF7 cells upon ND treatment. To test this, we first investigated whether autophagy was involved in MCF7 cell survival under ND conditions. Chloroquine (CQ) and NH4Cl suppress lysosomal degradation by increasing lysosomal pH, thus suppressing autophagy [18,35]. CQ and NH4Cl were therefore used to inhibit ND-induced autophagy in our study. MCF7 cells were cultured in normal medium and EBSS with or without CQ. As shown in Fig. 2A and 2B, 18 h of ND+CQ treatment significantly increased the number of apoptotic cells compared to ND-only conditions for 36 h. ND+CQ treatment for 36 h resulted in the breakdown of almost all cells (data not shown). CQ treatment alone for 18 h or 36 h barely interfered with cell apoptosis. This result suggests that normal autophagic flux is required for the survival of MCF7 cells under ND conditions. CQ can severely block autophagic flux by suppressing lysosomal degradation. When treated with ND + CQ, cell survival greatly decreased, and apoptosis occurred rapidly.
Fig 2
The different sensitivity to nutrient deprivation (ND) caused by YAP is attenuated after autophagy inhibition.
(A) MCF7 cells were cultured under the indicated conditions for 36 h without chloroquine (CQ) or for 18 h with CQ, stained by Annexin V-FITC/PI, and analyzed with flow cytometry. Representative results are shown. (B) Quantitative analysis of percentages of apoptotic cells according to results of (A) are expressed as the percentage of Annexin V-positive cells out of the total number of cells in the gate. Data are shown as the means±SEM. *P<0.05, n = 3. (C) After 38 h (without CQ) or 18 h (with CQ) of indicated treatments, MCF7-shCtrl, shYAP and YAP Res cell viability was determined by MTT assay. *P<0.05, n = 3. (D) After 38 h (without CQ/NH4Cl) or 18 h (with CQ/NH4Cl) of indicated treatments, MCF7-shCtrl, shYAP and YAP Res cells were stained by Annexin V-FITC/PI and analyzed with flow cytometry. (E) Quantitative analysis of percentages of apoptotic cells according to the results of (D) was assayed as previously. Data are shown as the means±SEM. *P<0.05, n = 3. (F) MCF7-shCtrl and shYAP cells were transfected with control (Ctrl) and LC3 siRNA for 48 h and treated with ND for 36 h. Cells were then stained by Annexin V-FITC/PI and analyzed with flow cytometry. Quantitative analysis of percentages of apoptotic cells is derived from triplicates. *P<0.05, n = 3. (G) MCF7-shCtrl and shYAP cells were transfected with control (Ctrl) and LC3 siRNA for 48 h and cultured in normal medium or EBSS (ND) for 36 h. Cell viability was determined by MTT assay. *P<0.05, n = 3. (H) MCF7-shCtrl and shYAP cells were transfected with the indicated siRNA for 48 h and cultured in normal medium or EBSS (ND) for 36 h. Representative blots are shown. The experiment was repeated twice.
The different sensitivity to nutrient deprivation (ND) caused by YAP is attenuated after autophagy inhibition.
(A) MCF7 cells were cultured under the indicated conditions for 36 h without chloroquine (CQ) or for 18 h with CQ, stained by Annexin V-FITC/PI, and analyzed with flow cytometry. Representative results are shown. (B) Quantitative analysis of percentages of apoptotic cells according to results of (A) are expressed as the percentage of Annexin V-positive cells out of the total number of cells in the gate. Data are shown as the means±SEM. *P<0.05, n = 3. (C) After 38 h (without CQ) or 18 h (with CQ) of indicated treatments, MCF7-shCtrl, shYAP and YAP Res cell viability was determined by MTT assay. *P<0.05, n = 3. (D) After 38 h (without CQ/NH4Cl) or 18 h (with CQ/NH4Cl) of indicated treatments, MCF7-shCtrl, shYAP and YAP Res cells were stained by Annexin V-FITC/PI and analyzed with flow cytometry. (E) Quantitative analysis of percentages of apoptotic cells according to the results of (D) was assayed as previously. Data are shown as the means±SEM. *P<0.05, n = 3. (F) MCF7-shCtrl and shYAP cells were transfected with control (Ctrl) and LC3 siRNA for 48 h and treated with ND for 36 h. Cells were then stained by Annexin V-FITC/PI and analyzed with flow cytometry. Quantitative analysis of percentages of apoptotic cells is derived from triplicates. *P<0.05, n = 3. (G) MCF7-shCtrl and shYAP cells were transfected with control (Ctrl) and LC3 siRNA for 48 h and cultured in normal medium or EBSS (ND) for 36 h. Cell viability was determined by MTT assay. *P<0.05, n = 3. (H) MCF7-shCtrl and shYAP cells were transfected with the indicated siRNA for 48 h and cultured in normal medium or EBSS (ND) for 36 h. Representative blots are shown. The experiment was repeated twice.Next, we determined if the YAP knockdown decreased MC7 cell survival under ND conditions was mediated by autophagy. MTT assay showed that, when autophagy was inhibited, the viability of shCtrl, shYAP and YAP Res cells all decreased. Viability differences between these cell lines were no longer significant (Fig. 2C). Furthermore, Annexin V-FITC/PI staining showed that the apoptosis levels greatly increased in all three cell lines under ND+CQ and ND+NH4Cl conditions compared with ND alone. More importantly, the significant differences in the apoptotic levels between shYAP and shCtrl or YAP Res cells under ND conditions were attenuated following autophagy inhibition (Fig. 2D and 2E). Consistently, siRNA-mediated knockdown of LC3 in MCF7-shCtrl and shYAP cells attenuated the different levels of apoptosis (Fig. 2F), viability (Fig. 2G) and cleaved PARP (Fig. 2H) between MCF7-shCtrl and shYAP cells under ND conditions. These observations demonstrate that autophagy is critical for YAP to protect MCF7 cells from apoptosis under nutrient deprivation.
YAP affects autophagic flux in breast cancer cells
Next, we investigated whether aberrant YAP protein levels interfered with autophagy directly. Both LC3-II and p62 protein levels were used as indicators of autophagic flux. It has been reported that monitoring LC3-II levels in the presence and absence of inhibitors more accurately estimates lysosomal degradation during starvation-induced autophagy [18,36,37]. Thus, MCF7-shCtrl and shYAP cells were cultured under ND conditions in the presence or absence of lysosome inhibitors (CQ or Bafilomycin A1 (BafA1)) for different times. Whole-cell lysates were subjected to Western blotting for changes in LC3-II and p62. Previous studies showed that in MCF7 cells, EBSS treatment resulted in decreased LC3-II levels caused by faster degradation [38-40]. Consistently, in our experiment, ND treatment led to marked degradation of LC3-II, as well as p62, in MCF7-shCtrl cells at all time-points examined (Fig. 3A, lanes 3, 5,13), suggesting that ND increased the autophagic flux in MCF7-shCtrl cells. However, there was less LC3-II and p62 degradation in shYAP cells upon ND treatment than in shCtrl cells (Fig. 3A, lanes 4, 6, 14). If treated with ND+CQ or ND+BafA1, LC3-II and p62 degradation in both shCtrl and shYAP cells was inhibited (Fig. 3A, lanes 7–10, 15–18). Quantified relative LC3-II flux and p62 level analysis consistently showed that ND-induced autophagic flux was significantly inhibited by YAP knockdown (Fig. 3B and 3C). Expression of YAP rescue protein in shYAP cells eliminated the differences in autophagic flux between shCtrl and shYAP cells (Fig. 3D, lanes 3, 4 and 9, 10; Fig. 3E and 3F). Furthermore, increased LC3-II flux and p62 degradation were seen in cells expressing YAP rescue protein when cultured under ND stress (Fig. 3E and 3F). Knockdown of YAP in another breast cancer cell line, MDA-MB-231, also blocked LC3-II and p62 degradation (Fig. 3G). Consistently, over-expression of YAP in MDA-MB-231 increased LC3-II and p62 degradation (Fig. 3H). Immunofluorescence staining of endogenous LC3 puncta after ND treatment also obtained the consistent results (S2 Fig.). Together, these data demonstrate that YAP plays a role in increasing the autophagic flux of breast cancer cells under ND condition.
Fig 3
Knockdown of YAP inhibits autophagic flux in breast cancer cells.
(A) MCF7-shCtrl and shYAP cells were cultured in normal medium (ND 0 h or no treatment) or maintained in EBSS (ND) +vehicle control (VC) or EBSS +CQ or Bafilomycin A1 (BafA1) for 2,4, and 6 h. Total proteins were subjected to Western blotting for the indicated antibodies. Representative results are shown. (B) Quantified relative LC3-II flux according to the Western blot results of (A) is expressed as the normalized LC3-II ratio calculated by the levels of LC3-II in the presence of CQ divided by the levels of LC3-II in absence of CQ. Data are derived from three independent experiments and shown as the means±SEM. *P<0.05. (C) Quantitative relative p62 levels according to results of (A) are expressed as p62 levels after different treatments divided by that of no treatment. Data are derived from three independent experiments and shown as the means±SEM. *P<0.05. (D) MCF7-shCtrl, shYAP and YAP-rescue-overexpression cells were cultured in normal medium (ND 0 h or no treatment) or maintained in EBSS (ND)+Vehicle Control (VC) or EBSS +CQ for 6 h. Total proteins were assayed by Western blotting. Representative results are shown. (E) Quantitative relative LC3-II flux according to Western blot results of (D) was assayed as previous. Data are derived from three independent experiments and shown as the means±SEM. *P<0.05. (F) Quantified relative p62 levels according to the results of (D) were assayed as previous. Data are derived from three independent experiments and shown as the means±SEM. *P<0.05. (G) MDA-MB-231-shCtrl and shYAP cells were cultured for 4 h in normal medium (no treatment), EBSS+VC (ND) or EBSS+BafA1. Total proteins were assayed by Western blotting with indicated antibodies. (H) MDA-MB231-Control and YAP overexpression cells were cultured for 6 h in normal medium (no treatment), EBSS+VC (ND) or EBSS+BafA1. Total proteins were assayed by Western blotting.
Knockdown of YAP inhibits autophagic flux in breast cancer cells.
(A) MCF7-shCtrl and shYAP cells were cultured in normal medium (ND 0 h or no treatment) or maintained in EBSS (ND) +vehicle control (VC) or EBSS +CQ or Bafilomycin A1 (BafA1) for 2,4, and 6 h. Total proteins were subjected to Western blotting for the indicated antibodies. Representative results are shown. (B) Quantified relative LC3-II flux according to the Western blot results of (A) is expressed as the normalized LC3-II ratio calculated by the levels of LC3-II in the presence of CQ divided by the levels of LC3-II in absence of CQ. Data are derived from three independent experiments and shown as the means±SEM. *P<0.05. (C) Quantitative relative p62 levels according to results of (A) are expressed as p62 levels after different treatments divided by that of no treatment. Data are derived from three independent experiments and shown as the means±SEM. *P<0.05. (D) MCF7-shCtrl, shYAP and YAP-rescue-overexpression cells were cultured in normal medium (ND 0 h or no treatment) or maintained in EBSS (ND)+Vehicle Control (VC) or EBSS +CQ for 6 h. Total proteins were assayed by Western blotting. Representative results are shown. (E) Quantitative relative LC3-II flux according to Western blot results of (D) was assayed as previous. Data are derived from three independent experiments and shown as the means±SEM. *P<0.05. (F) Quantified relative p62 levels according to the results of (D) were assayed as previous. Data are derived from three independent experiments and shown as the means±SEM. *P<0.05. (G) MDA-MB-231-shCtrl and shYAP cells were cultured for 4 h in normal medium (no treatment), EBSS+VC (ND) or EBSS+BafA1. Total proteins were assayed by Western blotting with indicated antibodies. (H) MDA-MB231-Control and YAP overexpression cells were cultured for 6 h in normal medium (no treatment), EBSS+VC (ND) or EBSS+BafA1. Total proteins were assayed by Western blotting.
YAP interferes with autophagic flux by enhancing autolysosome degradation
Autophagy is a highly dynamic, multi-step process that can be modulated at several steps, including autophagosome formation, maturation, fusion with lysosomes to generate autolysosomes, and degradation [41]. To investigate which step was targeted by YAP, 3-methyladenine (3-MA) and CQ were used as inhibitors of autophagosome formation and degradation. We found that the differences in LC3-II and p62 degradation between MCF7-shCtrl and shYAP cells under ND were attenuated in the presence of CQ, but not 3-MA (Fig. 4A, 4B and 4C). Moreover, treatment of rapamycin (Rapa), an autophagosome formation inducer, did not lead to more increase of LC3-II level in shYAP cells compared with shCtrl and YAP Res cells (Fig. 4D). These data suggest that YAP might interfere with autophagy by targeting the degradation and not the formation step of autophagy.
Fig 4
YAP interferes with autophagic flux via enhancing autolysosome degradation.
(A) MCF7-shCtrl and shYAP cells were cultured for 6 h in normal medium (no treatment), EBSS (ND), EBSS+3-MA or EBSS+CQ. Total proteins were subjected to Western blotting. Representative results are shown. (B) Quantitative relative levels of LC3-II according to the results of (A) are expressed as LC3-II levels after different treatments (ND, ND+3-MA, ND+CQ) divided by that of no treatment. Data are derived from three independent experiments and shown as the means±SEM. *P<0.05. (C) Quantitative relative p62 levels according to the results of (A) are expressed as p62 levels after different treatments divided by that of no treatment. Data are derived from three independent experiments and shown as the means±SEM. *P<0.05. (D) MCF7-shCtrl, shYAP and YAP Res cells were treated with rapamycin (Rapa) or Rapa +CQ for 4 h. Total proteins were subjected to western blotting. Increased LC3-II levels were quantified as LC3-II levels after different Treats (Rapa, Rapa+CQ) subtract that of no treat. Quantitative data are derived from three independent experiments and shown as the means±SEM. *P<0.05. (E) Lysosomal acidification levels of MCF7-shCtrl, shYAP and YAP Res cells were assayed by flow cytometry after staining with LysoTracker Red. (F) ACP activities of MCF7-shCtrl, shYAP and YAP Res cells were assayed. (G) MCF7-shCtrl-tfLC3 and MCF7-shYAP-tfLC3 cells were starved in EBSS for 2 h. CQ was then added to elevate the lysosomal pH. Images of live cells were taken with a confocal microscope (Scale bar: 10 μm). (H) Percentages of cells with red puncta per field were counted and calculated. Data are shown as the means±SEM. *P<0.05, n = 3. (I) Percentages of cells with more than half the puncta yellow per field were counted and calculated. Data are shown as the means±SEM. *P<0.05, n = 3.
YAP interferes with autophagic flux via enhancing autolysosome degradation.
(A) MCF7-shCtrl and shYAP cells were cultured for 6 h in normal medium (no treatment), EBSS (ND), EBSS+3-MA or EBSS+CQ. Total proteins were subjected to Western blotting. Representative results are shown. (B) Quantitative relative levels of LC3-II according to the results of (A) are expressed as LC3-II levels after different treatments (ND, ND+3-MA, ND+CQ) divided by that of no treatment. Data are derived from three independent experiments and shown as the means±SEM. *P<0.05. (C) Quantitative relative p62 levels according to the results of (A) are expressed as p62 levels after different treatments divided by that of no treatment. Data are derived from three independent experiments and shown as the means±SEM. *P<0.05. (D) MCF7-shCtrl, shYAP and YAP Res cells were treated with rapamycin (Rapa) or Rapa +CQ for 4 h. Total proteins were subjected to western blotting. Increased LC3-II levels were quantified as LC3-II levels after different Treats (Rapa, Rapa+CQ) subtract that of no treat. Quantitative data are derived from three independent experiments and shown as the means±SEM. *P<0.05. (E) Lysosomal acidification levels of MCF7-shCtrl, shYAP and YAP Res cells were assayed by flow cytometry after staining with LysoTracker Red. (F) ACP activities of MCF7-shCtrl, shYAP and YAP Res cells were assayed. (G) MCF7-shCtrl-tfLC3 and MCF7-shYAP-tfLC3 cells were starved in EBSS for 2 h. CQ was then added to elevate the lysosomal pH. Images of live cells were taken with a confocal microscope (Scale bar: 10 μm). (H) Percentages of cells with red puncta per field were counted and calculated. Data are shown as the means±SEM. *P<0.05, n = 3. (I) Percentages of cells with more than half the puncta yellow per field were counted and calculated. Data are shown as the means±SEM. *P<0.05, n = 3.Functional lysosomes are critical for the maturation and degradation steps of autophagy. Lysosomal acidification is necessary for the catalytic activity of lysosomal enzymes. Therefore, we next examined the lysosomal acidification level by flow cytometry after live shCtrl, shYAP and YAP Res cells were stained with LysoTracker. Our data showed that there were no significant differences in LysoTracker staining between the different cell lines (Fig. 4E). The activity of acid phosphatase (ACP), a representative lysosomal enzyme, was not affected by aberrant YAP protein levels (Fig. 4F). These data indicate that the effect of YAP on autophagy is not via changing the lysosomal acidification.Tandem fluorescent mRFP-GFP-tagged LC3 (tfLC3) is designed to monitor autophagic flux [42]. The GFP signal is quenched in the acidic autolysosome, whereas mRFP is more stable. Therefore, colocalization of both GFP and mRFP fluorescence indicates an autophagosome that has not fused with a lysosome. In contrast, an mRFP signal without GFP corresponds to an autolysosome [43]. Cells cultured in EBSS led to increased quenching of the GFP signal, caused by more autophagosome/lysosome fusion and faster degradation of GFP-LC3 [44]. Chloroquine (CQ) and NH4Cl suppress lysosomal degradation by increasing lysosomal pH [18,35]. When treated with CQ or NH4Cl, the quenched GFP signal of tfLC3 localizing to autolysosomes will recover. In our experiment, MCF7-shCtrl and shYAP cells were stably transfected with a plasmid expressing tfLC3. The resulting cell lines were named MCF7-shCtrl-tfLC3 and MCF7-shYAP-tfLC3. When starved in EBSS for 2 h, the GFP signal was remarkably reduced in both cell lines, but the mRFP signal remained (Fig. 4G, 4H and 4I), suggesting that autophagosome/lysosome fusion occurred normally in both cell lines. However, when CQ was added to elevate lysosomal pH after 2 h of EBSS treatment, MCF7-shYAP-tfLC3 cells exhibited significantly more co-localization of GFP and mRFP fluorescence (yellow puncta) than MCF7-shYAP-tfLC3 cells (Fig. 4G, 4H and 4I). Similar results were obtained by using NH4Cl instead of CQ (data not shown). It has been reported that GFP-LC3 is degraded in a step-wise fashion in the autolysosome, in which free GFP fragments are first generated, but their accumulation depends on the capacity of lysosomal degradation [44]. The increased GFP signal in shYAP cells when CQ was added after 2 h of EBSS treatment indicated their reduced lysosomal degradation compared with shCtrl cells.Together, these data indicate that YAP may increase autolysosome degradation, but does not interfere with the fusion of autophagosomes and lysosomes.
YAP increase of autophagic flux is TEAD-dependent
TEAD family transcription factors (TEADs) are essential for mediating YAP-dependent gene expression and are also required for YAP-induced cell functions [28]. To investigate whether TEADs are involved in the regulation of autophagy by YAP, TEAD1/3/4 was knocked down in normal and YAP-overexpressing MCF7 cells. Western blotting showed that ND-induced degradation of LC3-II and p62 was remarkably weakened in TEAD1/3/4 knockdown cells (Fig. 5A). In addition, re-expression of YAP-S94A, a YAPSer94 to alanine (S94A) mutant that is defective in TEAD binding ability [28], did not enhance the ND-induced degradation of LC3-II and p62 as effectively as YAP-WT (Fig. 5B). Together, these data indicate the requirement of at least one of TEAD1/3/4 for YAP to increase autophagic flux.
Fig 5
YAP-increased autolysosome degradation is TEAD-dependent.
(A) TEAD1/3/4 was knocked down in normal and YAP-overexpressing MCF7 cells. Indicated cells were cultured for 6 h in normal medium (no treat), EBSS (ND) or EBSS +CQ. Total proteins were assayed by Western blotting. (B) MCF7-shYAP cells were stably infected with retrovirus expressing YAP-WT or YAP-S94A to generate WT Res and S94A Res cell lines. MCF7-shCtrl, shYAP, WT Ras and S94A Ras cells were cultured for 6 h in normal medium (no treatment), EBSS (ND) or EBSS +CQ. Total proteins were detected by Western blotting for indicated antibodies. (C) Images of normal cultured tfLC3-shYAP, tfLC3-WTr and tfLC3-S94Ar cells were taken with a confocal microscope. (D) YAP protein levels in MCF7-shCtrl-tfLC3, tfLC3-shYAP, tfLC3-WTr and tfLC3-S94Ar cell lines were determined. (E) tfLC3-shYAP, tfLC3-WTr and tfLC3-S94Ar cells were starved in EBSS for 2 h, and CQ was added to elevate lysosomal pH. Images of live cells were taken with a confocal microscope (Scale bar: 10 μm). (F) Average red and green fluorescent intensities per live cell in each well were valued by a high content cell assay microscope system. Green/red ratios were calculated and shown here. Data are shown as the means±SEM. *P<0.05, n = 3.
YAP-increased autolysosome degradation is TEAD-dependent.
(A) TEAD1/3/4 was knocked down in normal and YAP-overexpressing MCF7 cells. Indicated cells were cultured for 6 h in normal medium (no treat), EBSS (ND) or EBSS +CQ. Total proteins were assayed by Western blotting. (B) MCF7-shYAP cells were stably infected with retrovirus expressing YAP-WT or YAP-S94A to generate WT Res and S94A Res cell lines. MCF7-shCtrl, shYAP, WT Ras and S94A Ras cells were cultured for 6 h in normal medium (no treatment), EBSS (ND) or EBSS +CQ. Total proteins were detected by Western blotting for indicated antibodies. (C) Images of normal cultured tfLC3-shYAP, tfLC3-WTr and tfLC3-S94Ar cells were taken with a confocal microscope. (D) YAP protein levels in MCF7-shCtrl-tfLC3, tfLC3-shYAP, tfLC3-WTr and tfLC3-S94Ar cell lines were determined. (E) tfLC3-shYAP, tfLC3-WTr and tfLC3-S94Ar cells were starved in EBSS for 2 h, and CQ was added to elevate lysosomal pH. Images of live cells were taken with a confocal microscope (Scale bar: 10 μm). (F) Average red and green fluorescent intensities per live cell in each well were valued by a high content cell assay microscope system. Green/red ratios were calculated and shown here. Data are shown as the means±SEM. *P<0.05, n = 3.To obtain further evidence that YAP increases autophagic flux via TEAD, cells with high-fluorescence-intensity puncta in MCF7-shYAP-tfLC3 cell line were selected by flow cytometry. High-fluorescence-intensity-puncta cells, called tfLC3-shYAP, were stably infected with retroviruses expressing YAP-WT or YAP-S94A to generate the tfLC3-WTr and tfLC3-S94Ar cell lines (Fig. 5C and 5D). After 2 h of starvation in EBSS, the GFP puncta signals in tfLC3-shYAP, tfLC3-WTr and tfLC3-S94Ar cell lines were quenched similarly (Fig. 5E and 5F). However, when CQ was added to elevate the lysosomal pH after 2 h of EBSS treatment, tfLC3-WTr cells exhibited significantly less colocalization of GFP and mRFP fluorescence than the other two cell lines (Fig. 5E and 5F). Taken together, these data indicate that YAP increases autolysosome degradation in a TEAD-dependent manner.
Discussion
The role of YAP in breast cancer remains elusive. In this study, we found that YAP knockdown sensitizes breast cancer cells to nutrient deprivation-induced apoptosis. Our work further revealed that upon ND, YAP increases autolysosome degradation, thereby enhancing cellular autophagic flux to protect breast cancer cells from ND-induced apoptosis. Thus, our study highlights a role for YAP in promoting breast cancer cell survival upon ND stress.Under conditions of metabolic stress such as ND, autophagy is induced to provide the nutrients and energy required for cell viability. For instance, autophagy may promote the survival of starved tumor cells in regions of the tumor with poor blood supply [45]. Accumulating evidence reveals that autophagy plays a critical role in breast cancer biology and therapy. A recent study demonstrated that Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells [40]. Another study showed that the suppression of autophagy by the deletion of FIP200 (200 kDa FAK family interacting protein), an important regulator of autophagy in mammalian cells, inhibits mammary tumorigenesis [46]. Therefore, these data support a role for autophagy in breast cancer.To date, the interplay between the Hippo/MST pathway and the cellular autophagy machinery has not been thoroughly investigated. Recently, Maejima et al. showed that the mammalian STE20-like kinase-1 (MST-1) subverts autophagy and promotes apoptosis in the heart [26], suggesting a role for the MST/YAP pathway in integrating autophagy and apoptosis during cellular stress. However, it is largely unknown whether autophagy plays a critical role in MST/YAP pathway-mediated tumor suppression. In the present work, we first provide evidence that YAP can protect MCF7 cells from nutrient deprivation-induced apoptosis, indicating a role for YAP in breast cancer survival under ND. Our data further reveal that this protective function of YAP is mediated by autophagy, consistent with a recent study by Liang et al reporting that nutrient starvation promotes YAP degradation concomitantly with the induction of autophagy in a chloroquine-sensitive manner [34]. Importantly, Liang et al revealed that mTOR regulates YAP degradation through autophagy [34]. More specifically, we revealed that YAP enhanced autophagosome degradation, thereby increasing the autophagic flux in nutrient deprived breast cancer cells. Moreover, TEADs are involved in the YAP-mediated regulation of autophagy. Thus, our findings suggest a novel mechanism, via targeting autophagy, by which YAP promotes breast cancer cell survival under ND. This notion is consistent with the recent discovery that MST phosphorylates the Thr108 residue in the BH3 domain of Beclin 1 to inhibit autophagy, thereby promoting apoptosis [26], as YAP’s biological function is generally inhibited by MST in the Hippo pathway. Although we show that YAP does not exert a direct effect on lysosome acidification and the fusion of autophagosomes with lysosomes in breast cancer cells under ND conditions, our data suggest that YAP and TEAD may regulate gene expression, leading to increased autophagy via enhancing autolysosome degradation. Thus, YAP and TEAD probably regulate the expression of lysosomal enzymes or proteins related to lysosomal enzyme sorting to the lysosome, such as M6P receptors. The detailed molecular mechanism underlying the YAP regulation of autophagy needs to be further investigated.Given the growing amount of literature documenting both oncogenic and growth suppressive roles for YAP in breast cancer, the precise contribution of YAP to breast cancer may be complex. In this study, we show that in response to ND, YAP promotes breast cancer cell survival by augmenting autophagic flux. Therefore, our findings underscore YAP as a potential target for breast cancer treatment.
Overexpression of YAP enhances autophagic flux, but has no significant effect on ND-induced apoptosis in MCF7 and MDA-MB-231 cells.
(A) MCF7-Ctrl and YAP cells were cultured in normal medium (ND 0 h or no treatment) or maintained in EBSS (ND) +vehicle control (VC) or EBSS +CQ for 6 h. Total proteins were subjected to Western blotting for indicated antibodies. Representative results are shown. (B) Quantified relative LC3-II flux according to Western blot results of (A). Data are derived from three independent experiments and shown as the means±SEM. *P<0.05. (C) Quantitative relative p62 levels according to the results of (A). *P<0.05. (D) MCF7-Ctrl and YAP cells were cultured in normal medium or EBSS (ND) for 36 h. Cell viability was determined by MTT assay. *P<0.05, n = 3. (E) After 36 h of ND, MCF7-Ctrl and YAP cells were stained by Annexin V-FITC/PI and analyzed with flow cytometry. Representative results are shown. Quantitative analysis of percentages of apoptotic cells is derived from triplicates. *P<0.05. (F) After 18 h (without CQ) or 8 h (with CQ) of indicated treatments, MDA-MB-231-shCtrl and shYAP cell viability was determined by MTT assay. *P<0.05, n = 3. (F) After 18 h of ND, MDA-MB231-Ctrl and YAP cell viability was determined by MTT assay. *P<0.05, n = 3.(TIF)Click here for additional data file.
Knockdown of YAP results in more LC3 puncta maintained in breast cancer cells under ND conditions.
(A) Immunofluorescent images of LC3 in MCF7-shCtrl, shYAP and YAP Res cells, after treatment with ND or ND+CQ condition for 2 h. Representative images are shown. Quantification of LC3 puncta was determined from three independent experiments in which at least 30 cells with more than 10 puncta were counted. *P<0.05. (B) Immunofluorescent images of LC3 in MDA-MB-231-shCtrl and shYAP cells, after treatment with ND or ND+CQ for 2 h. Representative images are shown. Quantification of LC3 puncta was determined likewise.(TIF)Click here for additional data file.
Authors: Daniel J Klionsky; Fabio C Abdalla; Hagai Abeliovich; Robert T Abraham; Abraham Acevedo-Arozena; Khosrow Adeli; Lotta Agholme; Maria Agnello; Patrizia Agostinis; Julio A Aguirre-Ghiso; Hyung Jun Ahn; Ouardia Ait-Mohamed; Slimane Ait-Si-Ali; Takahiko Akematsu; Shizuo Akira; Hesham M Al-Younes; Munir A Al-Zeer; Matthew L Albert; Roger L Albin; Javier Alegre-Abarrategui; Maria Francesca Aleo; Mehrdad Alirezaei; Alexandru Almasan; Maylin Almonte-Becerril; Atsuo Amano; Ravi Amaravadi; Shoba Amarnath; Amal O Amer; Nathalie Andrieu-Abadie; Vellareddy Anantharam; David K Ann; Shailendra Anoopkumar-Dukie; Hiroshi Aoki; Nadezda Apostolova; Giuseppe Arancia; John P Aris; Katsuhiko Asanuma; Nana Y O Asare; Hisashi Ashida; Valerie Askanas; David S Askew; Patrick Auberger; Misuzu Baba; Steven K Backues; Eric H Baehrecke; Ben A Bahr; Xue-Yuan Bai; Yannick Bailly; Robert Baiocchi; Giulia Baldini; Walter Balduini; Andrea Ballabio; Bruce A Bamber; Edward T W Bampton; Gábor Bánhegyi; Clinton R Bartholomew; Diane C Bassham; Robert C Bast; Henri Batoko; Boon-Huat Bay; Isabelle Beau; Daniel M Béchet; Thomas J Begley; Christian Behl; Christian Behrends; Soumeya Bekri; Bryan Bellaire; Linda J Bendall; Luca Benetti; Laura Berliocchi; Henri Bernardi; Francesca Bernassola; Sébastien Besteiro; Ingrid Bhatia-Kissova; Xiaoning Bi; Martine Biard-Piechaczyk; Janice S Blum; Lawrence H Boise; Paolo Bonaldo; David L Boone; Beat C Bornhauser; Karina R Bortoluci; Ioannis Bossis; Frédéric Bost; Jean-Pierre Bourquin; Patricia Boya; Michaël Boyer-Guittaut; Peter V Bozhkov; Nathan R Brady; Claudio Brancolini; Andreas Brech; Jay E Brenman; Ana Brennand; Emery H Bresnick; Patrick Brest; Dave Bridges; Molly L Bristol; Paul S Brookes; Eric J Brown; John H Brumell; Nicola Brunetti-Pierri; Ulf T Brunk; Dennis E Bulman; Scott J Bultman; Geert Bultynck; Lena F Burbulla; Wilfried Bursch; Jonathan P Butchar; Wanda Buzgariu; Sergio P Bydlowski; Ken Cadwell; Monika Cahová; Dongsheng Cai; Jiyang Cai; Qian Cai; Bruno Calabretta; Javier Calvo-Garrido; Nadine Camougrand; Michelangelo Campanella; Jenny Campos-Salinas; Eleonora Candi; Lizhi Cao; Allan B Caplan; Simon R Carding; Sandra M Cardoso; Jennifer S Carew; Cathleen R Carlin; Virginie Carmignac; Leticia A M Carneiro; Serena Carra; Rosario A Caruso; Giorgio Casari; Caty Casas; Roberta Castino; Eduardo Cebollero; Francesco Cecconi; Jean Celli; Hassan Chaachouay; Han-Jung Chae; Chee-Yin Chai; David C Chan; Edmond Y Chan; Raymond Chuen-Chung Chang; Chi-Ming Che; Ching-Chow Chen; Guang-Chao Chen; Guo-Qiang Chen; Min Chen; Quan Chen; Steve S-L Chen; WenLi Chen; Xi Chen; Xiangmei Chen; Xiequn Chen; Ye-Guang Chen; Yingyu Chen; Yongqiang Chen; Yu-Jen Chen; Zhixiang Chen; Alan Cheng; Christopher H K Cheng; Yan Cheng; Heesun Cheong; Jae-Ho Cheong; Sara Cherry; Russ Chess-Williams; Zelda H Cheung; Eric Chevet; Hui-Ling Chiang; Roberto Chiarelli; Tomoki Chiba; Lih-Shen Chin; Shih-Hwa Chiou; Francis V Chisari; Chi Hin Cho; Dong-Hyung Cho; Augustine M K Choi; DooSeok Choi; Kyeong Sook Choi; Mary E Choi; Salem Chouaib; Divaker Choubey; Vinay Choubey; Charleen T Chu; Tsung-Hsien Chuang; Sheau-Huei Chueh; Taehoon Chun; Yong-Joon Chwae; Mee-Len Chye; Roberto Ciarcia; Maria R Ciriolo; Michael J Clague; Robert S B Clark; Peter G H Clarke; Robert Clarke; Patrice Codogno; Hilary A Coller; María I Colombo; Sergio Comincini; Maria Condello; Fabrizio Condorelli; Mark R Cookson; Graham H Coombs; Isabelle Coppens; Ramon Corbalan; Pascale Cossart; Paola Costelli; Safia Costes; Ana Coto-Montes; Eduardo Couve; Fraser P Coxon; James M Cregg; José L Crespo; Marianne J Cronjé; Ana Maria Cuervo; Joseph J Cullen; Mark J Czaja; Marcello D'Amelio; Arlette Darfeuille-Michaud; Lester M Davids; Faith E Davies; Massimo De Felici; John F de Groot; Cornelis A M de Haan; Luisa De Martino; Angelo De Milito; Vincenzo De Tata; Jayanta Debnath; Alexei Degterev; Benjamin Dehay; Lea M D Delbridge; Francesca Demarchi; Yi Zhen Deng; Jörn Dengjel; Paul Dent; Donna Denton; Vojo Deretic; Shyamal D Desai; Rodney J Devenish; Mario Di Gioacchino; Gilbert Di Paolo; Chiara Di Pietro; Guillermo Díaz-Araya; Inés Díaz-Laviada; Maria T Diaz-Meco; Javier Diaz-Nido; Ivan Dikic; Savithramma P Dinesh-Kumar; Wen-Xing Ding; Clark W Distelhorst; Abhinav Diwan; Mojgan Djavaheri-Mergny; Svetlana Dokudovskaya; Zheng Dong; Frank C Dorsey; Victor Dosenko; James J Dowling; Stephen Doxsey; Marlène Dreux; Mark E Drew; Qiuhong Duan; Michel A Duchosal; Karen Duff; Isabelle Dugail; Madeleine Durbeej; Michael Duszenko; Charles L Edelstein; Aimee L Edinger; Gustavo Egea; Ludwig Eichinger; N Tony Eissa; Suhendan Ekmekcioglu; Wafik S El-Deiry; Zvulun Elazar; Mohamed Elgendy; Lisa M Ellerby; Kai Er Eng; Anna-Mart Engelbrecht; Simone Engelender; Jekaterina Erenpreisa; Ricardo Escalante; Audrey Esclatine; Eeva-Liisa Eskelinen; Lucile Espert; Virginia Espina; Huizhou Fan; Jia Fan; Qi-Wen Fan; Zhen Fan; Shengyun Fang; Yongqi Fang; Manolis Fanto; Alessandro Fanzani; Thomas Farkas; Jean-Claude Farré; Mathias Faure; Marcus Fechheimer; Carl G Feng; Jian Feng; Qili Feng; Youji Feng; László Fésüs; Ralph Feuer; Maria E Figueiredo-Pereira; Gian Maria Fimia; Diane C Fingar; Steven Finkbeiner; Toren Finkel; Kim D Finley; Filomena Fiorito; Edward A Fisher; Paul B Fisher; Marc Flajolet; Maria L Florez-McClure; Salvatore Florio; Edward A Fon; Francesco Fornai; Franco Fortunato; Rati Fotedar; Daniel H Fowler; Howard S Fox; Rodrigo Franco; Lisa B Frankel; Marc Fransen; José M Fuentes; Juan Fueyo; Jun Fujii; Kozo Fujisaki; Eriko Fujita; Mitsunori Fukuda; Ruth H Furukawa; Matthias Gaestel; Philippe Gailly; Malgorzata Gajewska; Brigitte Galliot; Vincent Galy; Subramaniam Ganesh; Barry Ganetzky; Ian G Ganley; Fen-Biao Gao; George F Gao; Jinming Gao; Lorena Garcia; Guillermo Garcia-Manero; Mikel Garcia-Marcos; Marjan Garmyn; Andrei L Gartel; Evelina Gatti; Mathias Gautel; Thomas R Gawriluk; Matthew E Gegg; Jiefei Geng; Marc Germain; Jason E Gestwicki; David A Gewirtz; Saeid Ghavami; Pradipta Ghosh; Anna M Giammarioli; Alexandra N Giatromanolaki; Spencer B Gibson; Robert W Gilkerson; Michael L Ginger; Henry N Ginsberg; Jakub Golab; Michael S Goligorsky; Pierre Golstein; Candelaria Gomez-Manzano; Ebru Goncu; Céline Gongora; Claudio D Gonzalez; Ramon Gonzalez; Cristina González-Estévez; Rosa Ana González-Polo; Elena Gonzalez-Rey; Nikolai V Gorbunov; Sharon Gorski; Sandro Goruppi; Roberta A Gottlieb; Devrim Gozuacik; Giovanna Elvira Granato; Gary D Grant; Kim N Green; Aleš Gregorc; Frédéric Gros; Charles Grose; Thomas W Grunt; Philippe Gual; Jun-Lin Guan; Kun-Liang Guan; Sylvie M Guichard; Anna S Gukovskaya; Ilya Gukovsky; Jan Gunst; Asa B Gustafsson; Andrew J Halayko; Amber N Hale; Sandra K Halonen; Maho Hamasaki; Feng Han; Ting Han; Michael K Hancock; Malene Hansen; Hisashi Harada; Masaru Harada; Stefan E Hardt; J Wade Harper; Adrian L Harris; James Harris; Steven D Harris; Makoto Hashimoto; Jeffrey A Haspel; Shin-ichiro Hayashi; Lori A Hazelhurst; Congcong He; You-Wen He; Marie-Joseé Hébert; Kim A Heidenreich; Miep H Helfrich; Gudmundur V Helgason; Elizabeth P Henske; Brian Herman; Paul K Herman; Claudio Hetz; Sabine Hilfiker; Joseph A Hill; Lynne J Hocking; Paul Hofman; Thomas G Hofmann; Jörg Höhfeld; Tessa L Holyoake; Ming-Huang Hong; David A Hood; Gökhan S Hotamisligil; Ewout J Houwerzijl; Maria Høyer-Hansen; Bingren Hu; Chien-An A Hu; Hong-Ming Hu; Ya Hua; Canhua Huang; Ju Huang; Shengbing Huang; Wei-Pang Huang; Tobias B Huber; Won-Ki Huh; Tai-Ho Hung; Ted R Hupp; Gang Min Hur; James B Hurley; Sabah N A Hussain; Patrick J Hussey; Jung Jin Hwang; Seungmin Hwang; Atsuhiro Ichihara; Shirin Ilkhanizadeh; Ken Inoki; Takeshi Into; Valentina Iovane; Juan L Iovanna; Nancy Y Ip; Yoshitaka Isaka; Hiroyuki Ishida; Ciro Isidoro; Ken-ichi Isobe; Akiko Iwasaki; Marta Izquierdo; Yotaro Izumi; Panu M Jaakkola; Marja Jäättelä; George R Jackson; William T Jackson; Bassam Janji; Marina Jendrach; Ju-Hong Jeon; Eui-Bae Jeung; Hong Jiang; Hongchi Jiang; Jean X Jiang; Ming Jiang; Qing Jiang; Xuejun Jiang; Xuejun Jiang; Alberto Jiménez; Meiyan Jin; Shengkan Jin; Cheol O Joe; Terje Johansen; Daniel E Johnson; Gail V W Johnson; Nicola L Jones; Bertrand Joseph; Suresh K Joseph; Annie M Joubert; Gábor Juhász; Lucienne Juillerat-Jeanneret; Chang Hwa Jung; Yong-Keun Jung; Kai Kaarniranta; Allen Kaasik; Tomohiro Kabuta; Motoni Kadowaki; Katarina Kagedal; Yoshiaki Kamada; Vitaliy O Kaminskyy; Harm H Kampinga; Hiromitsu Kanamori; Chanhee Kang; Khong Bee Kang; Kwang Il Kang; Rui Kang; Yoon-A Kang; Tomotake Kanki; Thirumala-Devi Kanneganti; Haruo Kanno; Anumantha G Kanthasamy; Arthi Kanthasamy; Vassiliki Karantza; Gur P Kaushal; Susmita Kaushik; Yoshinori Kawazoe; Po-Yuan Ke; John H Kehrl; Ameeta Kelekar; Claus Kerkhoff; David H Kessel; Hany Khalil; Jan A K W Kiel; Amy A Kiger; Akio Kihara; Deok Ryong Kim; Do-Hyung Kim; Dong-Hou Kim; Eun-Kyoung Kim; Hyung-Ryong Kim; Jae-Sung Kim; Jeong Hun Kim; Jin Cheon Kim; John K Kim; Peter K Kim; Seong Who Kim; Yong-Sun Kim; Yonghyun Kim; Adi Kimchi; Alec C Kimmelman; Jason S King; Timothy J Kinsella; Vladimir Kirkin; Lorrie A Kirshenbaum; Katsuhiko Kitamoto; Kaio Kitazato; Ludger Klein; Walter T Klimecki; Jochen Klucken; Erwin Knecht; Ben C B Ko; Jan C Koch; Hiroshi Koga; Jae-Young Koh; Young Ho Koh; Masato Koike; Masaaki Komatsu; Eiki Kominami; Hee Jeong Kong; Wei-Jia Kong; Viktor I Korolchuk; Yaichiro Kotake; Michael I Koukourakis; Juan B Kouri Flores; Attila L Kovács; Claudine Kraft; Dimitri Krainc; Helmut Krämer; Carole Kretz-Remy; Anna M Krichevsky; Guido Kroemer; Rejko Krüger; Oleg Krut; Nicholas T Ktistakis; Chia-Yi Kuan; Roza Kucharczyk; Ashok Kumar; Raj Kumar; Sharad Kumar; Mondira Kundu; Hsing-Jien Kung; Tino Kurz; Ho Jeong Kwon; Albert R La Spada; Frank Lafont; Trond Lamark; Jacques Landry; Jon D Lane; Pierre Lapaquette; Jocelyn F Laporte; Lajos László; Sergio Lavandero; Josée N Lavoie; Robert Layfield; Pedro A Lazo; Weidong Le; Laurent Le Cam; Daniel J Ledbetter; Alvin J X Lee; Byung-Wan Lee; Gyun Min Lee; Jongdae Lee; Ju-Hyun Lee; Michael Lee; Myung-Shik Lee; Sug Hyung Lee; Christiaan Leeuwenburgh; Patrick Legembre; Renaud Legouis; Michael Lehmann; Huan-Yao Lei; Qun-Ying Lei; David A Leib; José Leiro; John J Lemasters; Antoinette Lemoine; Maciej S Lesniak; Dina Lev; Victor V Levenson; Beth Levine; Efrat Levy; Faqiang Li; Jun-Lin Li; Lian Li; Sheng Li; Weijie Li; Xue-Jun Li; Yan-bo Li; Yi-Ping Li; Chengyu Liang; Qiangrong Liang; Yung-Feng Liao; Pawel P Liberski; Andrew Lieberman; Hyunjung J Lim; Kah-Leong Lim; Kyu Lim; Chiou-Feng Lin; Fu-Cheng Lin; Jian Lin; Jiandie D Lin; Kui Lin; Wan-Wan Lin; Weei-Chin Lin; Yi-Ling Lin; Rafael Linden; Paul Lingor; Jennifer Lippincott-Schwartz; Michael P Lisanti; Paloma B Liton; Bo Liu; Chun-Feng Liu; Kaiyu Liu; Leyuan Liu; Qiong A Liu; Wei Liu; Young-Chau Liu; Yule Liu; Richard A Lockshin; Chun-Nam Lok; Sagar Lonial; Benjamin Loos; Gabriel Lopez-Berestein; Carlos López-Otín; Laura Lossi; Michael T Lotze; Peter Lőw; Binfeng Lu; Bingwei Lu; Bo Lu; Zhen Lu; Frédéric Luciano; Nicholas W Lukacs; Anders H Lund; Melinda A Lynch-Day; Yong Ma; Fernando Macian; Jeff P MacKeigan; Kay F Macleod; Frank Madeo; Luigi Maiuri; Maria Chiara Maiuri; Davide Malagoli; May Christine V Malicdan; Walter Malorni; Na Man; Eva-Maria Mandelkow; Stéphen Manon; Irena Manov; Kai Mao; Xiang Mao; Zixu Mao; Philippe Marambaud; Daniela Marazziti; Yves L Marcel; Katie Marchbank; Piero Marchetti; Stefan J Marciniak; Mateus Marcondes; Mohsen Mardi; Gabriella Marfe; Guillermo Mariño; Maria Markaki; Mark R Marten; Seamus J Martin; Camille Martinand-Mari; Wim Martinet; Marta Martinez-Vicente; Matilde Masini; Paola Matarrese; Saburo Matsuo; Raffaele Matteoni; Andreas Mayer; Nathalie M Mazure; David J McConkey; Melanie J McConnell; Catherine McDermott; Christine McDonald; Gerald M McInerney; Sharon L McKenna; BethAnn McLaughlin; Pamela J McLean; Christopher R McMaster; G Angus McQuibban; Alfred J Meijer; Miriam H Meisler; Alicia Meléndez; Thomas J Melia; Gerry Melino; Maria A Mena; Javier A Menendez; Rubem F S Menna-Barreto; Manoj B Menon; Fiona M Menzies; Carol A Mercer; Adalberto Merighi; Diane E Merry; Stefania Meschini; Christian G Meyer; Thomas F Meyer; Chao-Yu Miao; Jun-Ying Miao; Paul A M Michels; Carine Michiels; Dalibor Mijaljica; Ana Milojkovic; Saverio Minucci; Clelia Miracco; Cindy K Miranti; Ioannis Mitroulis; Keisuke Miyazawa; Noboru Mizushima; Baharia Mograbi; Simin Mohseni; Xavier Molero; Bertrand Mollereau; Faustino Mollinedo; Takashi Momoi; Iryna Monastyrska; Martha M Monick; Mervyn J Monteiro; Michael N Moore; Rodrigo Mora; Kevin Moreau; Paula I Moreira; Yuji Moriyasu; Jorge Moscat; Serge Mostowy; Jeremy C Mottram; Tomasz Motyl; Charbel E-H Moussa; Sylke Müller; Sylviane Muller; Karl Münger; Christian Münz; Leon O Murphy; Maureen E Murphy; Antonio Musarò; Indira Mysorekar; Eiichiro Nagata; Kazuhiro Nagata; Aimable Nahimana; Usha Nair; Toshiyuki Nakagawa; Kiichi Nakahira; Hiroyasu Nakano; Hitoshi Nakatogawa; Meera Nanjundan; Naweed I Naqvi; Derek P Narendra; Masashi Narita; Miguel Navarro; Steffan T Nawrocki; Taras Y Nazarko; Andriy Nemchenko; Mihai G Netea; Thomas P Neufeld; Paul A Ney; Ioannis P Nezis; Huu Phuc Nguyen; Daotai Nie; Ichizo Nishino; Corey Nislow; Ralph A Nixon; Takeshi Noda; Angelika A Noegel; Anna Nogalska; Satoru Noguchi; Lucia Notterpek; Ivana Novak; Tomoyoshi Nozaki; Nobuyuki Nukina; Thorsten Nürnberger; Beat Nyfeler; Keisuke Obara; Terry D Oberley; Salvatore Oddo; Michinaga Ogawa; Toya Ohashi; Koji Okamoto; Nancy L Oleinick; F Javier Oliver; Laura J Olsen; Stefan Olsson; Onya Opota; Timothy F Osborne; Gary K Ostrander; Kinya Otsu; Jing-hsiung James Ou; Mireille Ouimet; Michael Overholtzer; Bulent Ozpolat; Paolo Paganetti; Ugo Pagnini; Nicolas Pallet; Glen E Palmer; Camilla Palumbo; Tianhong Pan; Theocharis Panaretakis; Udai Bhan Pandey; Zuzana Papackova; Issidora Papassideri; Irmgard Paris; Junsoo Park; Ohkmae K Park; Jan B Parys; Katherine R Parzych; Susann Patschan; Cam Patterson; Sophie Pattingre; John M Pawelek; Jianxin Peng; David H Perlmutter; Ida Perrotta; George Perry; Shazib Pervaiz; Matthias Peter; Godefridus J Peters; Morten Petersen; Goran Petrovski; James M Phang; Mauro Piacentini; Philippe Pierre; Valérie Pierrefite-Carle; Gérard Pierron; Ronit Pinkas-Kramarski; Antonio Piras; Natik Piri; Leonidas C Platanias; Stefanie Pöggeler; Marc Poirot; Angelo Poletti; Christian Poüs; Mercedes Pozuelo-Rubio; Mette Prætorius-Ibba; Anil Prasad; Mark Prescott; Muriel Priault; Nathalie Produit-Zengaffinen; Ann Progulske-Fox; Tassula Proikas-Cezanne; Serge Przedborski; Karin Przyklenk; Rosa Puertollano; Julien Puyal; Shu-Bing Qian; Liang Qin; Zheng-Hong Qin; Susan E Quaggin; Nina Raben; Hannah Rabinowich; Simon W Rabkin; Irfan Rahman; Abdelhaq Rami; Georg Ramm; Glenn Randall; Felix Randow; V Ashutosh Rao; Jeffrey C Rathmell; Brinda Ravikumar; Swapan K Ray; Bruce H Reed; John C Reed; Fulvio Reggiori; Anne Régnier-Vigouroux; Andreas S Reichert; John J Reiners; Russel J Reiter; Jun Ren; José L Revuelta; Christopher J Rhodes; Konstantinos Ritis; Elizete Rizzo; Jeffrey Robbins; Michel Roberge; Hernan Roca; Maria C Roccheri; Stephane Rocchi; H Peter Rodemann; Santiago Rodríguez de Córdoba; Bärbel Rohrer; Igor B Roninson; Kirill Rosen; Magdalena M Rost-Roszkowska; Mustapha Rouis; Kasper M A Rouschop; Francesca Rovetta; Brian P Rubin; David C Rubinsztein; Klaus Ruckdeschel; Edmund B Rucker; Assaf Rudich; Emil Rudolf; Nelson Ruiz-Opazo; Rossella Russo; Tor Erik Rusten; Kevin M Ryan; Stefan W Ryter; David M Sabatini; Junichi Sadoshima; Tapas Saha; Tatsuya Saitoh; Hiroshi Sakagami; Yasuyoshi Sakai; Ghasem Hoseini Salekdeh; Paolo Salomoni; Paul M Salvaterra; Guy Salvesen; Rosa Salvioli; Anthony M J Sanchez; José A Sánchez-Alcázar; Ricardo Sánchez-Prieto; Marco Sandri; Uma Sankar; Poonam Sansanwal; Laura Santambrogio; Shweta Saran; Sovan Sarkar; Minnie Sarwal; Chihiro Sasakawa; Ausra Sasnauskiene; Miklós Sass; Ken Sato; Miyuki Sato; Anthony H V Schapira; Michael Scharl; Hermann M Schätzl; Wiep Scheper; Stefano Schiaffino; Claudio Schneider; Marion E Schneider; Regine Schneider-Stock; Patricia V Schoenlein; Daniel F Schorderet; Christoph Schüller; Gary K Schwartz; Luca Scorrano; Linda Sealy; Per O Seglen; Juan Segura-Aguilar; Iban Seiliez; Oleksandr Seleverstov; Christian Sell; Jong Bok Seo; Duska Separovic; Vijayasaradhi Setaluri; Takao Setoguchi; Carmine Settembre; John J Shacka; Mala Shanmugam; Irving M Shapiro; Eitan Shaulian; Reuben J Shaw; James H Shelhamer; Han-Ming Shen; Wei-Chiang Shen; Zu-Hang Sheng; Yang Shi; Kenichi Shibuya; Yoshihiro Shidoji; Jeng-Jer Shieh; Chwen-Ming Shih; Yohta Shimada; Shigeomi Shimizu; Takahiro Shintani; Orian S Shirihai; Gordon C Shore; Andriy A Sibirny; Stan B Sidhu; Beata Sikorska; Elaine C M Silva-Zacarin; Alison Simmons; Anna Katharina Simon; Hans-Uwe Simon; Cristiano Simone; Anne Simonsen; David A Sinclair; Rajat Singh; Debasish Sinha; Frank A Sinicrope; Agnieszka Sirko; Parco M Siu; Efthimios Sivridis; Vojtech Skop; Vladimir P Skulachev; Ruth S Slack; Soraya S Smaili; Duncan R Smith; Maria S Soengas; Thierry Soldati; Xueqin Song; Anil K Sood; Tuck Wah Soong; Federica Sotgia; Stephen A Spector; Claudia D Spies; Wolfdieter Springer; Srinivasa M Srinivasula; Leonidas Stefanis; Joan S Steffan; Ruediger Stendel; Harald Stenmark; Anastasis Stephanou; Stephan T Stern; Cinthya Sternberg; Björn Stork; Peter Strålfors; Carlos S Subauste; Xinbing Sui; David Sulzer; Jiaren Sun; Shi-Yong Sun; Zhi-Jun Sun; Joseph J Y Sung; Kuninori Suzuki; Toshihiko Suzuki; Michele S Swanson; Charles Swanton; Sean T Sweeney; Lai-King Sy; Gyorgy Szabadkai; Ira Tabas; Heinrich Taegtmeyer; Marco Tafani; Krisztina Takács-Vellai; Yoshitaka Takano; Kaoru Takegawa; Genzou Takemura; Fumihiko Takeshita; Nicholas J Talbot; Kevin S W Tan; Keiji Tanaka; Kozo Tanaka; Daolin Tang; Dingzhong Tang; Isei Tanida; Bakhos A Tannous; Nektarios Tavernarakis; Graham S Taylor; Gregory A Taylor; J Paul Taylor; Lance S Terada; Alexei Terman; Gianluca Tettamanti; Karin Thevissen; Craig B Thompson; Andrew Thorburn; Michael Thumm; FengFeng Tian; Yuan Tian; Glauco Tocchini-Valentini; Aviva M Tolkovsky; Yasuhiko Tomino; Lars Tönges; Sharon A Tooze; Cathy Tournier; John Tower; Roberto Towns; Vladimir Trajkovic; Leonardo H Travassos; Ting-Fen Tsai; Mario P Tschan; Takeshi Tsubata; Allan Tsung; Boris Turk; Lorianne S Turner; Suresh C Tyagi; Yasuo Uchiyama; Takashi Ueno; Midori Umekawa; Rika Umemiya-Shirafuji; Vivek K Unni; Maria I Vaccaro; Enza Maria Valente; Greet Van den Berghe; Ida J van der Klei; Wouter van Doorn; Linda F van Dyk; Marjolein van Egmond; Leo A van Grunsven; Peter Vandenabeele; Wim P Vandenberghe; Ilse Vanhorebeek; Eva C Vaquero; Guillermo Velasco; Tibor Vellai; Jose Miguel Vicencio; Richard D Vierstra; Miquel Vila; Cécile Vindis; Giampietro Viola; Maria Teresa Viscomi; Olga V Voitsekhovskaja; Clarissa von Haefen; Marcela Votruba; Keiji Wada; Richard Wade-Martins; Cheryl L Walker; Craig M Walsh; Jochen Walter; Xiang-Bo Wan; Aimin Wang; Chenguang Wang; Dawei Wang; Fan Wang; Fen Wang; Guanghui Wang; Haichao Wang; Hong-Gang Wang; Horng-Dar Wang; Jin Wang; Ke Wang; Mei Wang; Richard C Wang; Xinglong Wang; Xuejun Wang; Ying-Jan Wang; Yipeng Wang; Zhen Wang; Zhigang Charles Wang; Zhinong Wang; Derick G Wansink; Diane M Ward; Hirotaka Watada; Sarah L Waters; Paul Webster; Lixin Wei; Conrad C Weihl; William A Weiss; Scott M Welford; Long-Ping Wen; Caroline A Whitehouse; J Lindsay Whitton; Alexander J Whitworth; Tom Wileman; John W Wiley; Simon Wilkinson; Dieter Willbold; Roger L Williams; Peter R Williamson; Bradly G Wouters; Chenghan Wu; Dao-Cheng Wu; William K K Wu; Andreas Wyttenbach; Ramnik J Xavier; Zhijun Xi; Pu Xia; Gengfu Xiao; Zhiping Xie; Zhonglin Xie; Da-zhi Xu; Jianzhen Xu; Liang Xu; Xiaolei Xu; Ai Yamamoto; Akitsugu Yamamoto; Shunhei Yamashina; Michiaki Yamashita; Xianghua Yan; Mitsuhiro Yanagida; Dun-Sheng Yang; Elizabeth Yang; Jin-Ming Yang; Shi Yu Yang; Wannian Yang; Wei Yuan Yang; Zhifen Yang; Meng-Chao Yao; Tso-Pang Yao; Behzad Yeganeh; Wei-Lien Yen; Jia-jing Yin; Xiao-Ming Yin; Ook-Joon Yoo; Gyesoon Yoon; Seung-Yong Yoon; Tomohiro Yorimitsu; Yuko Yoshikawa; Tamotsu Yoshimori; Kohki Yoshimoto; Ho Jin You; Richard J Youle; Anas Younes; Li Yu; Long Yu; Seong-Woon Yu; Wai Haung Yu; Zhi-Min Yuan; Zhenyu Yue; Cheol-Heui Yun; Michisuke Yuzaki; Olga Zabirnyk; Elaine Silva-Zacarin; David Zacks; Eldad Zacksenhaus; Nadia Zaffaroni; Zahra Zakeri; Herbert J Zeh; Scott O Zeitlin; Hong Zhang; Hui-Ling Zhang; Jianhua Zhang; Jing-Pu Zhang; Lin Zhang; Long Zhang; Ming-Yong Zhang; Xu Dong Zhang; Mantong Zhao; Yi-Fang Zhao; Ying Zhao; Zhizhuang J Zhao; Xiaoxiang Zheng; Boris Zhivotovsky; Qing Zhong; Cong-Zhao Zhou; Changlian Zhu; Wei-Guo Zhu; Xiao-Feng Zhu; Xiongwei Zhu; Yuangang Zhu; Teresa Zoladek; Wei-Xing Zong; Antonio Zorzano; Jürgen Zschocke; Brian Zuckerbraun Journal: Autophagy Date: 2012-04 Impact factor: 16.016
Authors: C Gong; C Bauvy; G Tonelli; W Yue; C Deloménie; V Nicolas; Y Zhu; V Domergue; V Marin-Esteban; H Tharinger; L Delbos; H Gary-Gouy; A-P Morel; S Ghavami; E Song; P Codogno; M Mehrpour Journal: Oncogene Date: 2012-06-25 Impact factor: 9.867
Authors: Qian Chen; Nailing Zhang; Ryan S Gray; Huili Li; Andrew J Ewald; Cynthia A Zahnow; Duojia Pan Journal: Genes Dev Date: 2014-03-01 Impact factor: 11.361
Authors: Ning Liang; Chi Zhang; Patricia Dill; Ganna Panasyuk; Delphine Pion; Vonda Koka; Morgan Gallazzini; Eric N Olson; Hilaire Lam; Elizabeth P Henske; Zheng Dong; Udayan Apte; Nicolas Pallet; Randy L Johnson; Fabiola Terzi; David J Kwiatkowski; Jean-Yves Scoazec; Guido Martignoni; Mario Pende Journal: J Exp Med Date: 2014-10-06 Impact factor: 14.307
Authors: Maria New; Tim Van Acker; Jun-Ichi Sakamaki; Ming Jiang; Rebecca E Saunders; Jaclyn Long; Victoria M-Y Wang; Axel Behrens; Joana Cerveira; Padhmanand Sudhakar; Tamas Korcsmaros; Harold B J Jefferies; Kevin M Ryan; Michael Howell; Sharon A Tooze Journal: Cancer Res Date: 2019-02-14 Impact factor: 12.701